Drug Type CAR-T |
Synonyms O&D-001 |
Target |
Action modulators |
Mechanism BCMA modulators(B-cell maturation protein modulators), GPRC5D modulators(G-protein coupled receptor family C group 5member D modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory Multiple Myeloma | Phase 1 | China | 28 Oct 2025 | |
| Relapse multiple myeloma | Phase 1 | - | - |
NEWS Manual | Unknown | 1 | rbgtrcwoaw(lvvkdsfbcl) = gsdwcqlxyw xrshxkrbzz (myxjppkwcx ) View more | Positive | 28 Dec 2025 |





